Ò»ÆÚÖÎÁƽøÐÐÖУ¬Ï£Íû´ó¼ÒÄÜÌṩµãÏ£Íû£¬»òÕß¼õÉÙ²¡Í´µÄ·½·¨ ·µ»ØÐ¡Ä¾³æ²é¿´¸ü¶à
ºÈ¶ìѪ£¬ÓÐÆæ¼£·¢Éú¡£Äã¿ÉÒԲ鿴Öйú¹ÅÊéÓмÇÔØ¡£ÎÒ¼ÒÇ×ÆÝ¾Í·¢ÉúÁËÆæ¼££¬ÖÐÍíÆÚ³¦°©¸Î×ªÒÆ£¬¶ìѪ°ïÖúÁÙ´²ÖÎÓú¡£ÏÖÔÚ15ÄêÁË¡£¡£¡£
ÓÐÌõ¼þ¾Í¶àºÈһЩ¡£Ã»Ìõ¼þ¾ÍÉÙºÈһЩ¡£ºÈÒ»¶Îʱ¼ä²î²»¶àÁ½¸öÔ°ɡ£È¥¸´²éCEA Ææ¼£°ãϽµ
Èç¹ûÊÇÖ±½ÓºÈ¶ìѪ ½¨ÒéÿÖܺÈ1-2´Î¡£Èç¹û×ö³É¶³¸É·Û ÿÌì³ÔÒ»´Î Ò»´ÎÎå¿Ë¡£ÔçÉÏÆðÀ´¿Õ¸¹¡£
ÎÒÃÇÖÐÒ½Ò©£¬ÒûʳÕý³£µÄÇé¿öÏ£¬Ò»°ã¸¹²¿×ªÒƶ¼ÄÜÓÐЧ¡£
θ°©ivÆÚÓÐ×ªÒÆ¹À¼ÆÒ½ÉúÒѾºÍ¼ÒÊô˵µÃºÜÃ÷°×ÁË£¬¼ÓÇ¿²¡ÈËÓªÑø£¬Î人µÄʯººÆ½½ÌÊÚÊÇÖ×ÁöÁÙ´²ÓªÑøÖ§³ÖµÄµÚÒ»ÈË£¬Èç¹ûÓÐÌõ¼þÈ¥ÕÒÒ»ÌË£»ÁíÍâÕùÈ¡²Î¼ÓÐÂÒ©µÄÁÙ´²ÊÔÑ飬zolbetuximab pamiparib bemarituzumab fruquintinib bemarituzumab ipilimumab folinate; gimeracil; oteracil potassium; tegafur ipilimumab fruquintinib sintilimab ipilimumab andecaliximab avelumab pamiparib - avelumab rivoceranib encequidar; paclitaxel andecaliximab masitinib mesylate - tislelizumab - - tislelizumab encequidar; paclitaxel nimotuzumab ipilimumab nimotuzumab bemarituzumab sintilimab - - sintilimab camrelizumab paclitaxel rivoceranib trastuzumab avelumab È«Çòθ°©·½Ãæ´ó¸ÅÊÇÕ⼸¸öÒ©Îï½øÈëÁËÁÙ´²ÈýÆÚ£¬Äã²é²éÄÄЩ¸öÊʺÏÄãÇ×ÊôµÄ¡£ ËäÈ»À§ÄÑÖØÖØ£¬µ«ÊÇ»¹ÊÇÆÚÍûÆæ¼£¬
ºÈ¶ìѪ£¬ÓÐÆæ¼£·¢Éú¡£Äã¿ÉÒԲ鿴Öйú¹ÅÊéÓмÇÔØ¡£ÎÒ¼ÒÇ×ÆÝ¾Í·¢ÉúÁËÆæ¼££¬ÖÐÍíÆÚ³¦°©¸Î×ªÒÆ£¬¶ìѪ°ïÖúÁÙ´²ÖÎÓú¡£ÏÖÔÚ15ÄêÁË¡£¡£¡£
ÓÐÌõ¼þ¾Í¶àºÈһЩ¡£Ã»Ìõ¼þ¾ÍÉÙºÈһЩ¡£ºÈÒ»¶Îʱ¼ä²î²»¶àÁ½¸öÔ°ɡ£È¥¸´²éCEA Ææ¼£°ãϽµ
Èç¹ûÊÇÖ±½ÓºÈ¶ìѪ ½¨ÒéÿÖܺÈ1-2´Î¡£Èç¹û×ö³É¶³¸É·Û ÿÌì³ÔÒ»´Î Ò»´ÎÎå¿Ë¡£ÔçÉÏÆðÀ´¿Õ¸¹¡£
ÎÒÃÇÖÐÒ½Ò©£¬ÒûʳÕý³£µÄÇé¿öÏ£¬Ò»°ã¸¹²¿×ªÒƶ¼ÄÜÓÐЧ¡£
θ°©ivÆÚÓÐ×ªÒÆ¹À¼ÆÒ½ÉúÒѾºÍ¼ÒÊô˵µÃºÜÃ÷°×ÁË£¬¼ÓÇ¿²¡ÈËÓªÑø£¬Î人µÄʯººÆ½½ÌÊÚÊÇÖ×ÁöÁÙ´²ÓªÑøÖ§³ÖµÄµÚÒ»ÈË£¬Èç¹ûÓÐÌõ¼þÈ¥ÕÒÒ»ÌË£»ÁíÍâÕùÈ¡²Î¼ÓÐÂÒ©µÄÁÙ´²ÊÔÑ飬zolbetuximab
pamiparib
bemarituzumab
fruquintinib
bemarituzumab
ipilimumab
folinate; gimeracil; oteracil potassium; tegafur
ipilimumab
fruquintinib
sintilimab
ipilimumab
andecaliximab
avelumab
pamiparib
-
avelumab
rivoceranib
encequidar; paclitaxel
andecaliximab
masitinib mesylate
-
tislelizumab
-
-
tislelizumab
encequidar; paclitaxel
nimotuzumab
ipilimumab
nimotuzumab
bemarituzumab
sintilimab
-
-
sintilimab
camrelizumab
paclitaxel
rivoceranib
trastuzumab
avelumab
È«Çòθ°©·½Ãæ´ó¸ÅÊÇÕ⼸¸öÒ©Îï½øÈëÁËÁÙ´²ÈýÆÚ£¬Äã²é²éÄÄЩ¸öÊʺÏÄãÇ×ÊôµÄ¡£
ËäÈ»À§ÄÑÖØÖØ£¬µ«ÊÇ»¹ÊÇÆÚÍûÆæ¼£¬